Literature DB >> 33428087

Biofilm-specific uptake of a 4-pyridone-based iron chelator by Pseudomonas aeruginosa.

Sharareh Houshmandyar1, Ian M Eggleston1, Albert Bolhuis2.   

Abstract

Iron is an essential nutrient for virtually all microbes and limiting the concentration of available iron is a potential strategy to be used as an alternative to antibiotic treatment. In this study we analysed the antimicrobial activity of two chelators, specifically 3-hydroxy-1,2-dimethyl-4(1H)-pyridone (deferiprone, DFP), which is clinically approved for the treatment of iron overload disorders, and its 1,2-diethyl homologue, CP94. Both compounds showed moderate activity towards planktonically growing P. aeruginosa cells, and the mechanism of action of these chelators was indeed by limiting the amount of free iron. Surprisingly, the compounds behaved very differently when the cells were grown in biofilms. DFP also showed inhibitory effects on biofilm formation but in contrast, CP94 stimulated this process, in particular at high concentrations. We hypothesised that CP94 behaves as an iron carrier, which was confirmed by our observation that it had antimicrobial synergy with the toxic metals, gallium and copper. This suggests that P. aeruginosa produces a biofilm-specific transport protein that recognises CP94 but not the closely related compound DFP.

Entities:  

Keywords:  Biofilm; CP94; Deferiprone (DFP); Iron chelator; Pseudomonas aeruginosa

Mesh:

Substances:

Year:  2021        PMID: 33428087      PMCID: PMC7940164          DOI: 10.1007/s10534-020-00281-x

Source DB:  PubMed          Journal:  Biometals        ISSN: 0966-0844            Impact factor:   2.949


  72 in total

1.  The antimicrobial and antibiofilm activities of copper(II) complexes.

Authors:  Michael L Beeton; Janice R Aldrich-Wright; Albert Bolhuis
Journal:  J Inorg Biochem       Date:  2014-07-22       Impact factor: 4.155

2.  Aminoglycoside antibiotics induce bacterial biofilm formation.

Authors:  Lucas R Hoffman; David A D'Argenio; Michael J MacCoss; Zhaoying Zhang; Roger A Jones; Samuel I Miller
Journal:  Nature       Date:  2005-08-25       Impact factor: 49.962

3.  In vitro activity of deferoxamine against Porphyromonas gingivalis.

Authors:  Ji-Hoi Moon; Yeek Herr; Sung-Woon Kim; Jin-Yong Lee
Journal:  FEMS Microbiol Lett       Date:  2011-08-05       Impact factor: 2.742

Review 4.  The Iron Tug-of-War between Bacterial Siderophores and Innate Immunity.

Authors:  Rachel Golonka; Beng San Yeoh; Matam Vijay-Kumar
Journal:  J Innate Immun       Date:  2019-01-03       Impact factor: 7.349

5.  An ABC transporter with two periplasmic binding proteins involved in iron acquisition in Pseudomonas aeruginosa.

Authors:  Karl Brillet; Frank Ruffenach; Hendrik Adams; Laure Journet; Véronique Gasser; Francoise Hoegy; Laurent Guillon; Mélissa Hannauer; Adeline Page; Isabelle J Schalk
Journal:  ACS Chem Biol       Date:  2012-10-05       Impact factor: 5.100

6.  Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma.

Authors:  S M Campbell; C A Morton; R Alyahya; S Horton; A Pye; A Curnow
Journal:  Br J Dermatol       Date:  2008-06-09       Impact factor: 9.302

7.  Pyridone-conjugated monobactam antibiotics with gram-negative activity.

Authors:  Matthew F Brown; Mark J Mitton-Fry; Joel T Arcari; Rose Barham; Jeffrey Casavant; Brian S Gerstenberger; Seungil Han; Joel R Hardink; Thomas M Harris; Thuy Hoang; Michael D Huband; Manjinder S Lall; M Megan Lemmon; Chao Li; Jian Lin; Sandra P McCurdy; Eric McElroy; Craig McPherson; Eric S Marr; John P Mueller; Lisa Mullins; Antonia A Nikitenko; Mark C Noe; Joseph Penzien; Mark S Plummer; Brandon P Schuff; Veerabahu Shanmugasundaram; Jeremy T Starr; Jianmin Sun; Andrew Tomaras; Jennifer A Young; Richard P Zaniewski
Journal:  J Med Chem       Date:  2013-06-27       Impact factor: 7.446

8.  Antibacterial activities of iron chelators against common nosocomial pathogens.

Authors:  Mitchell G Thompson; Brendan W Corey; Yuanzheng Si; David W Craft; Daniel V Zurawski
Journal:  Antimicrob Agents Chemother       Date:  2012-07-30       Impact factor: 5.191

Review 9.  Labile iron in cells and body fluids: physiology, pathology, and pharmacology.

Authors:  Zvi Ioav Cabantchik
Journal:  Front Pharmacol       Date:  2014-03-13       Impact factor: 5.810

Review 10.  Pseudomonas aeruginosa adapts its iron uptake strategies in function of the type of infections.

Authors:  Pierre Cornelis; Jozef Dingemans
Journal:  Front Cell Infect Microbiol       Date:  2013-11-14       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.